Hims & Hers down as judge denies motion over end to Lilly’s Zepbound shortage
H ims & Hers (NYSE:HIMS) fell ~8% in the premarket Thursday after a federal judge denied a motion filed by a compounding ...
Medscape1 个月
Cholesterol Agents Lead All Therapeutic Classes in Prescription Drug Sales
Also, the erectile dysfunction market saw 2 new launches late in 2003: GlaxoSmithKline's Levitra, and Cialis, marketed by Lilly Icos. Initial IMS findings show Pfizer's Viagra holding on to an 85% ...